The Shroom Boom and other Therapeutic Psychedelics for the Win
Setup
Mental-health and substance-use disorders — arguably more prevalent than ever during the pandemic — are a leading cause of disability globally. So it’s no wonder the clinical use of psychedelic drugs to help treat psychiatric disorders, including anxiety, depression, and PTSD, is fueling a research renaissance. Even Wall Street is taking notice: Three psychedelic drug developers have gone public in the last several months. Two leaders at the forefront of the field shed light on the science of psilocybin, MDMA, and ketamine and their use in psychedelic-assisted psychotherapy.
- 2021 Festival
- Health
Explore More
Health
As we wrap-up another year of elevating big ideas at Aspen Ideas: Health, we're excited to share the 15 most-watched sessions from the event. These conversations with inspirin...
In America, millions of people struggle with mental health including depression, anxiety, and more — all further exacerbated by living through a pandemic. The National Allianc...
Our attitudes, habits, pleasures, and responsibilities shift across the generations, influencing the health challenges we face and how we respond to them. Expectations about h...
The United States spends $4.3 trillion—almost one fifth of the nation’s GDP—on health care. As the scale of the medical enterprise expands, venture capitalists are pursuing th...
Today's kids are coming of age against a backdrop of political, social, technological and economic upheaval. While these circumstances are shaping a precocious generation that...
Advocates, healthcare providers, legislators, researchers, and venture capitalists are bringing the unique health needs of women to light – from vigorous policy debates on iss...
From the debate over reproductive rights to the epidemic of gun violence to the youth mental health crisis, this year's Aspen Ideas: Health sessions tackled many of today's mo...
The recognition that all things are connected is at once a scientific principle and a philosophical touchstone. Humans, animals, and the environment are intertwined in complex...
Our need for human connection is profound and deep. Yet, today, one in two adults are living with measurable levels of loneliness – and the numbers are even higher among young...
Artificial intelligence is revolutionizing health care by improving patient navigation, telehealth and the speed of drug development. From enhancing patient and provider exper...
Brain-computer interfaces show potential to restore function to people impacted by incurable neurological conditions such as stroke, spinal cord injury, traumatic brain injury...
Neurodivergent people make up 15% to 20% of the global population, and visionaries are busy trying to foster welcoming environments in areas like adaptive sports, fashion des...
Across the globe, humans are living and working longer than ever — and today’s systems, governments and businesses aren’t prepared. Examine how we can reimagine work, wealth a...
Given what we learned from the global turbulence from COVID-19, are we any more prepared for the next pandemic? Author and journalist Michael Lewis and Adar Poonawalla, CEO of...
Few people are more deeply steeped in science than Francis Collins, former director of the National Institutes of Health and the groundbreaking Human Genome Project, and forme...
Climate change is a threat multiplier with a disproportionate impact on vulnerable populations. Girls and women, who are denied equitable access to education and economic oppo...
Featuring inspiring conversations, the closing session is not to be missed. First, U.S. Surgeon General Vivek Murthy and Jennifer Ashton of ABC News explore the loneliness epi...
The experience of loss alters the map of the world imprinted on our brain, disrupting patterns and expectations as it struggles to form new ones. Grief is a kind of longing, n...
The hormonal changes and hot flashes that accompany menopause are familiar to most women, but the accompanying brain changes have not received as much attention. We now know t...
The idea of gathering DNA samples into a vast database in order to identify disease risks and breakthrough therapies was once a distant dream. Not long ago, immunotherapy seem...
